We offer our registered users tailored information, free online courses and exclusive content.
Reset it here.
We offer our registered users tailored information, free online courses and exclusive content.
Molecular pathology and biomarkers
Critical pathways in metastatic colorectal cancer (mCRC)
A. Sobrero (Italy)
Molecular biomarkers for mCRC
A. Sobrero (Italy)
Evidence-based recommendations for molecular testing of mCRC
C.H. Köhne (Germany)
Tumor heterogeneity and blood-based biomarkers
J. Taieb (France)
Treatment decisions in metastatic colorectal cancer (I)
RAS Wild-type and BRAF Wild-type mCRC
A. Sobrero (Italy)
Primary tumor location of RAS wild-type mCRC: left vs right
C.H. Köhne (Germany)
RAS mutated and BRAF mutated mCRC
J. Taieb (France)
Treatment decisions in metastatic colorectal cancer (II)
Oligometastatic disease
C.H. Köhne (Germany)
Therapy after progression
J. Taieb (France)
Spotlight - Molecular classification of CRC
C.H. Köhne (Germany)
Spotlight - Immunotherapy for mCRC
J. Taieb (France)